Hai V Nguyen
Overview
Explore the profile of Hai V Nguyen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bugden S, Mital S, Nguyen H
BMC Med
. 2025 Feb;
23(1):102.
PMID: 39984979
Background: Nirsevimab, a long-acting monoclonal antibody, and RSVpreF, a maternal vaccine, are newly approved respiratory syncytial virus (RSV) prophylactics for infants in Canada. Both have the potential to expand prevention...
2.
Nguyen H, Mital S
Health Econ
. 2024 Dec;
34(4):631-642.
PMID: 39719360
Existing evidence on whether e-cigarettes are substitutes or complements to combustible cigarettes is limited and mixed. We revisit this question using nationally-representative Canadian survey data over 14 years (2004-2017) and...
3.
Vincelette N, Yu X, Kuykendall A, Moon J, Su S, Cheng C, et al.
Blood Cancer Discov
. 2024 May;
5(4):276-297.
PMID: 38713018
Despite advances in understanding the genetic abnormalities in myeloproliferative neoplasms (MPN) and the development of JAK2 inhibitors, there is an urgent need to devise new treatment strategies, particularly for patients...
4.
Nguyen H, Mital S, McGinty E
JAMA Intern Med
. 2024 May;
184(7):848.
PMID: 38709508
No abstract available.
5.
Nguyen H, Mital S, Knopman D, Alexander G
Neurology
. 2024 Mar;
102(7):e209218.
PMID: 38484190
Background And Objectives: Little is known regarding the cost-effectiveness of lecanemab (Leqembi), a monoclonal antibody approved by the US Food and Drug Administration in January 2023 for the treatment of...
6.
Mital S, Bishop L, Bugden S, Grootendorst P, Nguyen H
Drug Alcohol Depend
. 2024 Mar;
257:111137.
PMID: 38460325
Background: There is increasing interest in understanding the impact of non-medical cannabis legalization on use of other substances, especially alcohol. Evidence on whether cannabis is a substitute or complement for...
7.
Nguyen H, McGinty E, Mital S, Alexander G
JAMA Health Forum
. 2024 Jan;
5(1):e234897.
PMID: 38241056
Importance: While some have argued that cannabis legalization has helped to reduce opioid-related morbidity and mortality in the US, evidence has been mixed. Moreover, existing studies did not account for...
8.
Nguyen H, Mital S, Bugden S, McGinty E
JAMA Intern Med
. 2024 Jan;
184(3):256-264.
PMID: 38227344
Importance: In March 2020, British Columbia, Canada, became the first jurisdiction globally to launch a large-scale provincewide safer supply policy. The policy allowed individuals with opioid use disorder at high...
9.
Mital S, Nguyen H
JAMA Netw Open
. 2023 Oct;
6(10):e2336400.
PMID: 37824146
Importance: Although the American Academy of Pediatrics has recommended treatment with antiobesity drugs for adolescents, the cost-effectiveness of antiobesity drugs for this population is still unknown. Objective: To quantify cost-effectiveness...
10.
Nguyen H, Tran L, Ly T, Pham Q, Pham V, Tran H, et al.
Cureus
. 2023 Aug;
15(8):e42923.
PMID: 37546691
Background The coronavirus disease 2019 (COVID-19) pandemic caused changes in surgical practice. For acute appendicitis (AA), measures to control the pandemic might hinder patients from seeking medical care timely, resulting...